Its not an overstatement to say were seeing an Ozempic baby boom, says Ob/Gyn Deidre McIntosh, MD
Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity), along with tirzepatide (Mounjaro, Zepbound)a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonistare effective medications for type 2 diabetes and weight management
Table 1 Summary of extracted clinical trials characteristics
Quick Answer: Most semaglutide side effects, particularly gastrointestinal symptoms like nausea, typically peak within 48 weeks and gradually improve over 23 months as tolerance develops
As research continues to evolve, so too will our understanding of how treatments like semaglutide can support individuals and couples on their path to parenthood